Palisade Bio says Phase 1b data show early gains for PALI-2108
Company says Phase 1b readouts include early endoscopic improvement, biomarker shifts consistent with PDE4 target engagement and favorable safety.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.